Charles P. Carey is Director at CME GROUP INC. (CME). They have made 16 open-market trades across 1 company since 2007, most recently 2026-06-25.
CIK 0001341358
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $602 since 2009, against 15 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CME | SELL | 2025-06-10 | 2025-06-11 | $265.35 | $226K | +0.3% | +1.7% | -3.3% |
| CME | SELL | 2025-05-15 | 2025-05-19 | $272.56 | $818K | +3.9% | -2.2% | -2.8% |
| CME | SELL | 2024-06-13 | 2024-06-14 | $195.44 | $586K | -0.4% | +0.3% | +10.6% |
| CME | SELL | 2022-02-10 | 2022-02-14 | $244.36 | $733K | -0.7% | +0.4% | -18.6% |
| CME | SELL | 2020-08-10 | 2020-08-12 | $165.39 | $1.3M | +3.6% | -3.5% | -0.2% |
| CME | SELL | 2019-05-07 | 2019-05-09 | $179.02 | $1.8M | +3.7% | +12.9% | +16.1% |
| CME | SELL | 2018-11-20 | 2018-11-23 | $191.84 | $959K | -0.5% | -7.0% | -7.1% |
| CME | SELL | 2018-11-02 | 2018-11-06 | $183.45 | $1.0M | +4.2% | +0.7% | -3.3% |
| CME | SELL | 2012-02-21 | 2012-02-22 | $290.26 | $637K | -5.2% | -0.1% | -0.1% |
| CME | BUY | 2009-09-21 | 2009-10-14 | $301.20 | $602 | -5.2% | -0.1% | -0.1% |
| CME | SELL | 2009-05-26 | 2009-05-28 | $301.60 | $151K | -5.2% | -0.1% | -0.1% |
| CME | SELL | 2009-04-29 | 2009-05-01 | $226.54 | $453K | -5.2% | -0.1% | -0.1% |
| CME | SELL | 2008-11-04 | 2008-11-06 | $320.99 | $642K | -5.2% | -0.1% | -0.1% |
| CME | SELL | 2008-04-24 | 2008-04-29 | $486.15 | $535K | -5.2% | -0.1% | -0.1% |
| CME | SELL | 2007-11-02 | 2007-11-05 | $646.95 | $388K | -5.2% | -0.1% | -0.1% |
| CME | SELL | 2007-10-29 | 2007-10-31 | $668.11 | $601K | -5.2% | -0.1% | -0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.